XOMA logo

XOMA

XOMA Royalty Corporation

$27.02
+$0.55(+2.06%)
26
Overall
30
Value
18
Tech
31
Quality
Market Cap
$431.53M
Volume
180.60K
52W Range
$18.35 - $39.92
Target Price
$64.50

Company Overview

Mkt Cap$431.53MPrice$27.02
Volume180.60KChange+2.06%
P/E Ratio-31.2Open$26.45
Revenue$6.7MPrev Close$26.47
Net Income$-13.8M52W Range$18.35 - $39.92
Div YieldN/ATarget$64.50
Overall26Value30
Quality31Technical18

No chart data available

About XOMA Royalty Corporation

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Sector: Healthcare
Industry: Biotechnology

Latest News

XOMA Royalty Appoints New Chief Financial Officer

Xoma ( ($XOMA) ) has shared an update. XOMA Royalty Corporation announced a leadership transition in its finance organization, effective January 12...

TipRanks Auto-Generated Newsdesk19 days ago

XOMA Highlights Royalty Growth Strategy in Updated Presentation

TipRanks Auto-Generated Newsdesk23 days ago
ABCD
1SymbolPriceChangeVol
2XOMA$27.02+2.1%180.60K
3
4
5
6

Get XOMA Royalty Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.